Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Engelhardt

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The European Journal of Neuroscience|January 24, 2015
Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in miceA U Joshi, C Orset, B Engelhardt, et al.
Acta Neurologica Scandinavica|September 2, 1998
Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosisJ Kraus, P Oschmann, B Engelhardt, et al.
Acta Neurologica Scandinavica|February 24, 2000
Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activityJ Kraus, P Oschmann, B Engelhardt, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 9, 2013
Correlation of abdominal rSO2 with superior mesenteric artery velocities in preterm infantsM Gillam-Krakauer, C M Cochran, J C Slaughter, et al.
Acta Neurologica Scandinavica|November 18, 2000
CD45RA+ ICAM-3+ lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosisJ Kraus, P Oschmann, B Engelhardt, et al.
The American Journal of Managed Care|February 9, 2006
Effects of a program for coordinated care of advanced illness on patients, surrogates, and healthcare costs: a randomized trialJoseph B Engelhardt, Kimberly P McClive-Reed, Ronald W Toseland, et al.
Methods of Information in Medicine|September 24, 2014
Combining cross-sectional data on prevalence with risk estimates from a prediction model. A novel method for estimating the attributable riskB Engelhardt, J König, M Blettner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitroJ Kraus, K Voigt, A M Schuller, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|October 8, 2004
Diabetes preventive care and non-traumatic lower extremity amputation ratesMichael E Moreland, Amy M Kilbourne, Joseph B Engelhardt, et al.
Medical Hypotheses|October 27, 2004
Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsiaJ W Downing, R Ramasubramanian, R F Johnson, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The European Journal of Neuroscience|January 24, 2015
Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in miceA U Joshi, C Orset, B Engelhardt, et al.
Acta Neurologica Scandinavica|September 2, 1998
Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosisJ Kraus, P Oschmann, B Engelhardt, et al.
Acta Neurologica Scandinavica|February 24, 2000
Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activityJ Kraus, P Oschmann, B Engelhardt, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 9, 2013
Correlation of abdominal rSO2 with superior mesenteric artery velocities in preterm infantsM Gillam-Krakauer, C M Cochran, J C Slaughter, et al.
Acta Neurologica Scandinavica|November 18, 2000
CD45RA+ ICAM-3+ lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosisJ Kraus, P Oschmann, B Engelhardt, et al.
The American Journal of Managed Care|February 9, 2006
Effects of a program for coordinated care of advanced illness on patients, surrogates, and healthcare costs: a randomized trialJoseph B Engelhardt, Kimberly P McClive-Reed, Ronald W Toseland, et al.
Methods of Information in Medicine|September 24, 2014
Combining cross-sectional data on prevalence with risk estimates from a prediction model. A novel method for estimating the attributable riskB Engelhardt, J König, M Blettner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitroJ Kraus, K Voigt, A M Schuller, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|October 8, 2004
Diabetes preventive care and non-traumatic lower extremity amputation ratesMichael E Moreland, Amy M Kilbourne, Joseph B Engelhardt, et al.
Medical Hypotheses|October 27, 2004
Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsiaJ W Downing, R Ramasubramanian, R F Johnson, et al.
Pageof 8